Literature DB >> 7731994

Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.

V Y Reddy1, Q Y Zhang, S J Weiss.   

Abstract

Human macrophages are believed to damage host tissues in chronic inflammatory disease states, but these cells have been reported to express only modest degradative activity in vitro. However, while examining the ability of human monocytes to degrade the extracellular matrix component elastin, we identified culture conditions under which the cells matured into a macrophage population that displayed a degradative phenotype hundreds of times more destructive than that previously ascribed to any other cell population. The monocyte-derived macrophages synthesized elastinolytic matrix metalloproteinases (i.e., gelatinase B and matrilysin) as well as cysteine proteinases (i.e., cathepsins B, L, and S), but only the cathepsins were detected in the extracellular milieu as fully processed, mature enzymes by either vital fluorescence or active-site labeling. Consistent with these observations, macrophage-mediated elastinolytic activity was not affected by matrix metalloproteinase inhibitors but could be almost completely abrogated by inhibiting cathepsins L and S. These data demonstrate that human macrophages mobilize cysteine proteinases to arm themselves with a powerful effector mechanism that can participate in the pathophysiologic remodeling of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731994      PMCID: PMC42059          DOI: 10.1073/pnas.92.9.3849

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

Review 2.  The role of cathepsin L in malignant transformation.

Authors:  S E Kane; M M Gottesman
Journal:  Semin Cancer Biol       Date:  1990-04       Impact factor: 15.707

3.  Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.

Authors:  V Everts; J M Delaissé; W Korper; A Niehof; G Vaes; W Beertsen
Journal:  J Cell Physiol       Date:  1992-02       Impact factor: 6.384

4.  The malignant phenotype and cysteine proteinases.

Authors:  B F Sloane; J Rozhin; E Krepela; G Ziegler; M Sameni
Journal:  Biomed Biochim Acta       Date:  1991

5.  The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

Authors:  B M Cullen; I M Halliday; G Kay; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

6.  Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes.

Authors:  H Kobayashi; N Moniwa; M Sugimura; H Shinohara; H Ohi; T Terao
Journal:  Biochim Biophys Acta       Date:  1993-07-28

7.  Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.

Authors:  L Goretzki; M Schmitt; K Mann; J Calvete; N Chucholowski; M Kramer; W A Günzler; F Jänicke; H Graeff
Journal:  FEBS Lett       Date:  1992-02-03       Impact factor: 4.124

8.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease.

Authors:  G P Shi; J S Munger; J P Meara; D H Rich; H A Chapman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

9.  Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis.

Authors:  W H Baricos; S L Cortez; Q C Le; L T Wu; E Shaw; K Hanada; S V Shah
Journal:  Arch Biochem Biophys       Date:  1991-08-01       Impact factor: 4.013

10.  Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases.

Authors:  P E Desrochers; K Mookhtiar; H E Van Wart; K A Hasty; S J Weiss
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

View more
  87 in total

Review 1.  Who are the proteolytic culprits in vascular disease?

Authors:  W C Parks
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Levels of cathepsins in acute myocardial infarction.

Authors:  Kavita K Shalia; Manoj R Mashru; Vinod K Shah; Surendra L Soneji; Satchidanand Payannavar
Journal:  Indian Heart J       Date:  2012 May-Jun

Review 3.  The role of cystatins in tick physiology and blood feeding.

Authors:  Alexandra Schwarz; James J Valdés; Michalis Kotsyfakis
Journal:  Ticks Tick Borne Dis       Date:  2012-04-20       Impact factor: 3.744

4.  The DEK nuclear autoantigen is a secreted chemotactic factor.

Authors:  Nirit Mor-Vaknin; Antonello Punturieri; Kajal Sitwala; Neil Faulkner; Maureen Legendre; Michael S Khodadoust; Ferdinand Kappes; Jeffrey H Ruth; Alisa Koch; David Glass; Lilli Petruzzelli; Barbara S Adams; David M Markovitz
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

5.  Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.

Authors:  Takashi Miyake; Motokuni Aoki; Mariana K Osako; Munehisa Shimamura; Hironori Nakagami; Ryuichi Morishita
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

Review 6.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

7.  The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.

Authors:  Aleksandra Glogowska; Janette Pyka; Astrid Kehlen; Marek Los; Paul Perumal; Ekkehard Weber; Sheue-yann Cheng; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

9.  Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Lang Zhuo
Journal:  Mol Biol Cell       Date:  2008-07-30       Impact factor: 4.138

10.  Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis.

Authors:  Farouc A Jaffer; Claudio Vinegoni; Michael C John; Elena Aikawa; Herman K Gold; Aloke V Finn; Vasilis Ntziachristos; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2008-10-13       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.